Ryan Jefferson Watts

USPTO Granted Patents = 38 (Patent Applications = 33)

CIPO Patents = 7 (Patent Applications = 3)

EPO Patents = 24 (Patent Applications = 19)

Average Co-Inventor Count = 4.5

ph-index = 10

Forward Citations = 329(Granted Patents)

Location History:

San Mateo, CA (US) (2010 - 2020)
South San Francisco, CA (US) (2017 - 2024)

Company Filing History:

Denali Therapeutics Inc.

Washington University

patents

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

38 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12162948 - Methods of engineering transferrin receptor binding polypeptides (2024-12-10),

2. 11926660 - Anti-ApoE antibodies (2024-03-12),

3. 11912778 - Methods of engineering transferrin receptor binding polypeptides (2024-02-27),

4. 11795232 - Engineered transferrin receptor binding polypeptides (2023-10-24),

5. 11746160 - Antibodies against BACE1 and use thereof for neural disease immunotherapy (2023-09-05),

6. 11167038 - Methods for improving safety of blood-brain barrier transport (2021-11-09),

7. 11124562 - Anti-ApoE antibodies (2021-09-21),

8. 11098129 - Anti-transferrin receptor antibodies and methods of use (2021-08-24),

9. 11008403 - Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of use (2021-05-18),

10. 10941215 - Low affinity blood brain barrier receptor antibodies and uses thereof (2021-03-09),

11. 10882920 - Antibodies against BACE1 and use thereof for neural disease immunotherapy (2021-01-05),

12. 10808036 - Anti-transferrin receptor antibodies and methods of use (2020-10-20),

13. 10508151 - Anti-transferrin receptor antibodies and methods of use (2019-12-17),

14. 9937224 - Modulation of axon degeneration (2018-04-10),

15. 9879094 - Nucleic acid molecules encoding for BACE1 antibodies (2018-01-30),

Title: The Innovative Mind of Ryan Jefferson Watts

Introduction:

Ryan Jefferson Watts, a prolific inventor based in San Mateo, CA (US), has made significant contributions to the field of medical research and biotechnology. With an impressive portfolio of 37 patents, his groundbreaking work has paved the way for new advancements in healthcare.

Latest Patents:

Among his latest patents is the development of Anti-ApoE antibodies, a cutting-edge approach to treating Aß plaque and cerebral amyloid angiopathy (CAA) associated symptoms. This method involves administering anti-ApoE antibodies to effectively target and reduce amyloid plaque load in mammalian subjects, including humans. Additionally, his work on engineering transferrin receptor binding polypeptides has opened up new possibilities for targeted drug delivery to transferrin receptor-expressing cells.

Career Highlights:

Ryan Jefferson Watts has lent his expertise to renowned companies such as Genentech, Inc. and AC Immune SA. Through his innovative research and strategic insights, he has played a key role in driving forward the R&D efforts of these organizations, leading to groundbreaking advancements in the healthcare industry.

Collaborations:

During his tenure at various companies, Ryan has collaborated closely with esteemed professionals like Yan Wu and Mark S. Dennis. Together, they have synergized their expertise to push the boundaries of medical science and bring forth novel solutions to complex healthcare challenges.

Conclusion:

In conclusion, Ryan Jefferson Watts stands as a beacon of innovation in the field of biotechnology and medical research. His numerous patents, collaborations with industry pioneers, and contributions to renowned companies underscore his remarkable impact on the healthcare landscape. As he continues to push the boundaries of scientific discovery, the future holds great promise for his pioneering work.

This text is generated by artificial intelligence and may not be accurate.